(NEW YORK)Opexa Therapeutics Inc. said Friday its lead drug candidate aimed at treating multiple sclerosis failed to meet its main goal in a midstage study, sending shares in a nosedive to a...READ MORE
(THE WOODLANDS, Texas)Biotechnology company Opexa Therapeutics Inc. said Tuesday its 2007 loss widened on higher research and development expenses. The company lost $14.7 million, or $2.19 per share, co...READ MORE